Cambria Investment Management »

Kyverna Therapeutics shares owned by Cambria Investment Management

Quarter-by-quarter ownership of Kyverna Therapeutics (KYTX) shares owned by Cambria Investment Management from 13F filings

Historical chart of Cambria Investment Management investment in Kyverna Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kyverna Therapeutics held by Cambria Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kyverna Therapeutics by Cambria Investment Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $169k 18k 9.40

More positions owned by Cambria Investment Management

Cambria Etf Tr Cambria Fgn Shr (FYLD)
Cambria Etf Tr Global Value Etf (GVAL)
Cambria Etf Tr Emrg Sharehldr (EYLD)
Cambria Etf Tr Value Momentum (VAMO)
Invesco Exch Traded Fd Tr Ii S&p500 Low Vol (SPLV)
Cambria Etf Tr Gbl Real Est Etf (BLDG)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vaneck Etf Trust Gold Miners Etf (GDX)
Spdr Series Trust Bloomberg Enhncd (CERY)
Exxon Mobil Corporation (XOM)
Cambria Etf Tr Glb Moment Etf (GMOM)
Graniteshares Gold Tr Shs Ben Int (BAR)
Tidal Trust Ii Cambria Chesapea (MFUT)
Litman Gregory Fds Tr Imgp Dbi Managed (DBMF)
Invesco Db Multi-sector Comm Precious Metal (DBP)

View all positions for Cambria Investment Management

Top funds holding Kyverna Therapeutics

Vida Ventures Advisors
Gilead Sciences
Bain Capital Life Sciences Investors
Deerfield Management Company
Vanguard Group
AIGH Capital Management
Insight Holdings
Woodline Partners
Propel Bio Management
Mbb Public Markets I
Alyeska Investment Group
Millennium Management
BlackRock
RFG Advisory
Susquehanna International

View all funds holding Kyverna Therapeutics